Delivery Order SPE2DB24D2100-SPE2DB25FBGJB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Tetracaine 0.5% Steri-Unit Solution in 4 ml quantities, with a ceiling value of $1,918.80 and an ultimate completion date of August 8, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the awardee's Conshohocken, Pennsylvania facility. The contract represents a small-value transaction typical of the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order valued at $1,389.36 to AmerisourceBergen Drug Corp on July 18, 2025, for Tetracaine 0.5% Steri-Unit Solution in 4mL units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 21, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,038.68 to AmerisourceBergen Drug Corp for Tetracaine 0.5% Steri-Unit Solution in 4 milliliter units. This firm fixed price delivery order, executed on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a non-set-aside competitive award. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,038.68 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Tetracaine 0.5% Steri-Unit Solution in 4 mL units, with an ultimate completion date of July 28, 2025. This contract award is not set-aside and utilizes firm fixed pricing under a competitive delivery order arrangement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,582.65 to AmerisourceBergen Drug Corp for Tetracaine 0.5% Steri-Unit Solution 4ML, a pharmaceutical product for military medical supply needs. This competitively awarded, firm fixed price contract was executed on August 13, 2025, with an ultimate completion date of August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,356.03 to AmerisourceBergen Drug Corp for Tetracaine 0.5% Steri-Unit Solution in 4 milliliter units. The contract was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and utilizes firm fixed pricing with no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive award under...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $1,746.68 to Amerisourcebergen Drug Corporation for the supply of 4562115821 Tetracaine 0.5% Steri-Unit Sol 4ml to be delivered to a location in Conshohocken, Pennsylvania between September 8-11, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will serve as the prime contractor on this contract issued against an unspecified government-wide acquisition...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,101.01 firm fixed-price delivery order is for the supply of 4565786481 - Tetracaine 1% (20 mg/2 ml) vials, with a period of performance through September 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract, valued at $2,626.78, is for the provision of 0.5% Tetracaine Steri-Unit Solution in 4 mL vials. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of tetracaine 0.5% eye solution. The contract has a ceiling value of $1,950.60 and a period of performance through March 21, 2024. Amerisourcebergen Drug Corp serves as the prime contractor, delivering pharmaceutical products and medical supplies to support military treatment...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBGJBDelivery Order
The Defense Logistics Agency awarded a $1,392.18 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Tetracaine 0.5% Steri-Unit Solution in 4mL units, with an ultimate completion date of September 16, 2025. This non-set-aside delivery order will be performed at the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfilled this order under its existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. This delivery order represents a routine pharmaceutical procurement supporting military healthcare operations through DLA's established supply chain for medical commodities. AmerisourceBergen's IDC with DLA enables the company to supply a broad range of pharmaceutical products, medical supplies, and specialty medications to support Defense Health Agency and other federal healthcare systems worldwide. The firm fixed pricing and rapid fulfillment timeline reflect the expedited nature of this particular medical supply need within the broader pharmaceutical prime vendor program structure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/15/25 |